Caribou Biosciences Stock Buy Hold or Sell Recommendation
| CRBU Stock | USD 0.94 0.05 5.05% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Caribou Biosciences is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Caribou Biosciences given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Caribou Biosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Caribou Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide. Note, we conduct extensive research on individual companies such as Caribou and provide practical buy, sell, or hold advice based on investors' constraints. Caribou Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Caribou |
Execute Caribou Biosciences Buy or Sell Advice
The Caribou recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Caribou Biosciences. Macroaxis does not own or have any residual interests in Caribou Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Caribou Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
3 Months |
Risk Tolerance
I am an educated risk taker |
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Caribou Biosciences Trading Alerts and Improvement Suggestions
| Caribou Biosciences generated a negative expected return over the last 90 days | |
| Caribou Biosciences has some characteristics of a very speculative penny stock | |
| Caribou Biosciences has high historical volatility and very poor performance | |
| Caribou Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 9.99 M. Net Loss for the year was (149.1 M) with loss before overhead, payroll, taxes, and interest of (119.56 M). | |
| Caribou Biosciences currently holds about 339.92 M in cash with (138.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Caribou Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 62.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Bronstein, Gewirtz Grossman, LLC Encourages Caribou Biosciences, Inc. Stockholders to Inquire about Securities Investigation - Markets Insider |
Caribou Biosciences Returns Distribution Density
The distribution of Caribou Biosciences' historical returns is an attempt to chart the uncertainty of Caribou Biosciences' future price movements. The chart of the probability distribution of Caribou Biosciences daily returns describes the distribution of returns around its average expected value. We use Caribou Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Caribou Biosciences returns is essential to provide solid investment advice for Caribou Biosciences.
| Mean Return | -0.89 |
| Value At Risk | -7.09 |
| Potential Upside | 5.66 |
| Standard Deviation | 4.26 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Caribou Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Caribou Stock Institutional Investors
The Caribou Biosciences' institutional investors refer to entities that pool money to purchase Caribou Biosciences' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | |||
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 1.7 M | |
| State Street Corp | 2024-12-31 | 1.7 M | |
| Fmr Inc | 2024-12-31 | 1.6 M | |
| Two Sigma Advisers, Llc | 2024-12-31 | 1.5 M | |
| Jacobs Levy Equity Management, Inc. | 2024-12-31 | 1.2 M | |
| Two Sigma Investments Llc | 2024-12-31 | 1.1 M | |
| Goldman Sachs Group Inc | 2024-12-31 | 1.1 M | |
| Point72 Asset Management, L.p. | 2024-12-31 | 1 M | |
| Fidelity International Ltd | 2024-12-31 | 860.7 K | |
| Blackrock Inc | 2024-12-31 | 6.6 M | |
| Pfizer Inc | 2024-12-31 | 4.7 M |
Caribou Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Caribou Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Caribou Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Caribou stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.83 | |
β | Beta against Dow Jones | 1.34 | |
σ | Overall volatility | 4.37 | |
Ir | Information ratio | -0.2 |
Caribou Biosciences Volatility Alert
Caribou Biosciences exhibits very low volatility with skewness of 0.65 and kurtosis of 0.81. Caribou Biosciences is a potential penny stock. Although Caribou Biosciences may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Caribou Biosciences. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Caribou instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Caribou Biosciences Fundamentals Vs Peers
Comparing Caribou Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Caribou Biosciences' direct or indirect competition across all of the common fundamentals between Caribou Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Caribou Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Caribou Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Caribou Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Caribou Biosciences to competition |
| Fundamentals | Caribou Biosciences | Peer Average |
| Return On Equity | -0.48 | -0.31 |
| Return On Asset | -0.27 | -0.14 |
| Operating Margin | (18.43) % | (5.51) % |
| Current Valuation | (95.71 M) | 16.62 B |
| Shares Outstanding | 93 M | 571.82 M |
| Shares Owned By Insiders | 10.08 % | 10.09 % |
| Shares Owned By Institutions | 61.69 % | 39.21 % |
| Number Of Shares Shorted | 8.91 M | 4.71 M |
| Price To Book | 0.35 X | 9.51 X |
| Price To Sales | 8.74 X | 11.42 X |
| Revenue | 9.99 M | 9.43 B |
| Gross Profit | (119.56 M) | 27.38 B |
| EBITDA | (166.62 M) | 3.9 B |
| Net Income | (149.1 M) | 570.98 M |
| Cash And Equivalents | 339.92 M | 2.7 B |
| Cash Per Share | 5.59 X | 5.01 X |
| Total Debt | 26.49 M | 5.32 B |
| Debt To Equity | 0.08 % | 48.70 % |
| Current Ratio | 12.23 X | 2.16 X |
| Book Value Per Share | 2.74 X | 1.93 K |
| Cash Flow From Operations | (138.2 M) | 971.22 M |
| Short Ratio | 8.49 X | 4.00 X |
| Earnings Per Share | (1.65) X | 3.12 X |
| Price To Earnings To Growth | 0.50 X | 4.89 X |
| Target Price | 12.0 | |
| Number Of Employees | 147 | 18.84 K |
| Beta | 2.34 | -0.15 |
| Market Capitalization | 87.34 M | 19.03 B |
| Total Asset | 313.31 M | 29.47 B |
| Retained Earnings | (448.39 M) | 9.33 B |
| Working Capital | 188.73 M | 1.48 B |
| Net Asset | 313.31 M |
Note: Insider Trading [view details]
Caribou Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Caribou . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 45111.99 | |||
| Daily Balance Of Power | (0.71) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 0.97 | |||
| Day Typical Price | 0.96 | |||
| Price Action Indicator | (0.05) | |||
| Period Momentum Indicator | (0.05) | |||
| Relative Strength Index | 37.39 |
About Caribou Biosciences Buy or Sell Advice
When is the right time to buy or sell Caribou Biosciences? Buying financial instruments such as Caribou Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Caribou Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency Thematic Idea Now
Cryptocurrency
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Caribou Stock Analysis
When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.